{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T06:53:00Z","timestamp":1769237580562,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,11,5]],"date-time":"2008-11-05T00:00:00Z","timestamp":1225843200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Immigrant Minority Health"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s10903-008-9204-9","type":"journal-article","created":{"date-parts":[[2008,11,4]],"date-time":"2008-11-04T07:41:23Z","timestamp":1225784483000},"page":"816-822","source":"Crossref","is-referenced-by-count":13,"title":["Prevalence of Tuberculin Skin Test Positivity in Clinical Population in New York City"],"prefix":"10.1007","volume":"12","author":[{"given":"Jiehui","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonal S.","family":"Munsiff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy B.","family":"Agerton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,5]]},"reference":[{"issue":"RR-6","key":"9204_CR1","first-page":"1","volume":"49","author":"Centers for Disease Control and Prevention (CDC)","year":"2000","unstructured":"Centers for Disease Control and Prevention (CDC). Targeted tuberculin testing and treatment of latent tuberculosis infection. Morb Mortal Wkly Rep. 2000;49(RR-6):1\u201351.","journal-title":"Morb Mortal Wkly Rep"},{"key":"9204_CR2","unstructured":"Institute of Medicine (US). Committee on the Elimination of Tuberculosis in the United States. In: Geiter L, editor. Ending neglect: the elimination of tuberculosis in the United States. Washington, DC: National Academy Press; 2000."},{"key":"9204_CR3","volume-title":"Reported Tuberculosis in the United States, 2006","author":"Centers for Disease Control, Prevention (CDC)","year":"2007","unstructured":"Centers for Disease Control, Prevention (CDC). Reported Tuberculosis in the United States, 2006. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2007."},{"key":"9204_CR4","unstructured":"New York City Department of Health and Mental Hygiene: Tuberculosis in New York City, 2005: Annual Summary. New York City Department of Health and Mental Hygiene; 2006."},{"issue":"3","key":"9204_CR5","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1164\/rccm.200701-057OC","volume":"177","author":"DE Bennett","year":"2007","unstructured":"Bennett DE, Courval JM, Onorato I, Agerton T, Daugherty Gibson J, Lambert L, et al. Prevalence of tuberculosis infection in the U.S. population. Am J Respir Crit Care Med. 2007;177(3):348\u201355.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"9204_CR6","first-page":"883","volume":"10","author":"TJ Joos","year":"2006","unstructured":"Joos TJ, Miller WC, Murdoch DM. Tuberculin reactivity in bacilli Calmette-Guerin vaccinated populations: a compilation of international data. Int J Tuberc Lung Dis. 2006;10(8):883\u201391.","journal-title":"Int J Tuberc Lung Dis"},{"key":"9204_CR7","unstructured":"New York City Department of City Planning. 2000 census profiles. Available at: http:\/\/www.nyc.gov\/html\/dcp\/pdf\/census.shtml ."},{"key":"9204_CR8","unstructured":"US Census Bureau. United States Census 2000: demographic profiles in the Unites States. Available at: http:\/\/censtats.census.gov\/data\/US\/01000.pdf ."},{"key":"9204_CR9","unstructured":"Fujiwara PI, Munsiff SS, Shapiro D. Testing and treatment for latent tuberculosis infection. City Health Information. New York: New York City Department of Health. 2000 Oct; 19(3). Available at: http:\/\/home2.nyc.gov\/html\/doh\/downloads\/pdf\/chi\/chi19-3.pdf ."},{"key":"9204_CR10","unstructured":"World Health Organization (WHO). Global tuberculosis control: surveillance, planning, financing. WHO Report 2005. Geneva, Switzerland, WHO\/HTM\/TB\/2005.349."},{"key":"9204_CR11","unstructured":"World Health Organization. WHO vaccine-preventable diseases: monitoring system: 2005 global summary. Geneva, Switzerland: WHO; 2005. WHO\/IVB\/2005. Available at www.who.int\/vaccines-documents\/ ."},{"key":"9204_CR12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/aje\/kwh221","volume":"160","author":"S Greenland","year":"2004","unstructured":"Greenland S. Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case-control studies. Am J Epidemiol. 2004;160:301\u20135.","journal-title":"Am J Epidemiol"},{"key":"9204_CR13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/aje\/kwi188","volume":"162","author":"D Spiegelman","year":"2005","unstructured":"Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol. 2005;162:199\u2013205.","journal-title":"Am J Epidemiol"},{"key":"9204_CR14","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1289\/ehp.6927","volume":"112","author":"N Pearce","year":"2004","unstructured":"Pearce N. Effect measures in prevalence studies. Environ Health Perspect. 2004;112:1047\u201350.","journal-title":"Environ Health Perspect"},{"key":"9204_CR15","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S1473-3099(04)01206-X","volume":"4","author":"M Pai","year":"2004","unstructured":"Pai M, Riley LW, Colford JM Jr. Interferon-\u03b3 assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis. 2004;4:761\u201376.","journal-title":"Lancet Infect Dis"},{"issue":"RR-15","key":"9204_CR16","first-page":"49","volume":"54","author":"GH Mazurek","year":"2005","unstructured":"Mazurek GH, Jereb J, LoBue P, Iademarco MF, Metchock B, Vernon A, et al. Guidelines for using the QuantFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep. 2005;54(RR-15):49\u201355.","journal-title":"MMWR Recomm Rep"},{"issue":"6","key":"9204_CR17","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S1473-3099(07)70086-5","volume":"7","author":"M Pai","year":"2007","unstructured":"Pai M, Dheda K, Cunningham J, Scano F, O\u2019Brien R. T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward. Lancet Infect Dis. 2007;7(6):428\u201338.","journal-title":"Lancet Infect Dis"},{"key":"9204_CR18","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1001\/jama.281.11.1014","volume":"281","author":"CM Nolan","year":"1999","unstructured":"Nolan CM, Goldberg SV, Buskin SE. Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic. JAMA. 1999;281:1014\u201318.","journal-title":"JAMA"},{"key":"9204_CR19","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.7326\/0003-4819-127-12-199712150-00001","volume":"127","author":"SR Salpeter","year":"1997","unstructured":"Salpeter SR, Sanders GD, Salpeter EE, Owens DK. Monitored isoniazid prophylaxis for low-risk tubercullin reactors older than 35\u00a0years of age: a risk-benefit and cost-effectiveness analysis. Ann Intern Med. 1997;127:1051\u201361.","journal-title":"Ann Intern Med"},{"key":"9204_CR20","first-page":"31","volume":"1","author":"NW Schluger","year":"1997","unstructured":"Schluger NW, Huberman R, Wolinsky N, Dooley R, Rom WN, Holzman RS. Tuberculosis infection and disease among persons seeking social services in New York City. Int J Tuberc Lung Dis. 1997;1:31\u20137.","journal-title":"Int J Tuberc Lung Dis"},{"key":"9204_CR21","first-page":"149","volume":"54","author":"J Hudson","year":"2005","unstructured":"Hudson J, Van Zetta S, Brissette B, Driver CR, Macaraig M, Winters A, et al. Tuberculosis transmission in a homeless shelter population\u2013New York, 2000\u20132003. MMWR. 2005;54:149\u201352.","journal-title":"MMWR"},{"issue":"11","key":"9204_CR22","first-page":"1192","volume":"10","author":"M Farhat","year":"2006","unstructured":"Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis. 2006;10(11):1192\u2013204.","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["Journal of Immigrant and Minority Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10903-008-9204-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10903-008-9204-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10903-008-9204-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T08:12:07Z","timestamp":1559463127000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10903-008-9204-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,5]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["9204"],"URL":"https:\/\/doi.org\/10.1007\/s10903-008-9204-9","relation":{},"ISSN":["1557-1912","1557-1920"],"issn-type":[{"value":"1557-1912","type":"print"},{"value":"1557-1920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,5]]}}}